NI
Neo Ivy Capital Management
13F filer · CIK 0001727783Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$434MU.S. long equity reported on 13F
Positions344204 new · 175 closed
Net flow last quarter-$21.6MBuys minus sells
Top 10 positions weight11.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026344 positions | |||||
| $6.22M | 1.43% | 0.02% | Not reported | Q3 2019 | |
| $5.44M | 1.25% | 0.00% | +4.0% | Q4 2018 | |
| $5.34M | 1.23% | 0.01% | Not reported | Q1 2021 | |
| $5.02M | 1.16% | 0.06% | Not reported | Q1 2021 | |
| $4.96M | 1.14% | 0.00% | +82.7% | Q3 2023 | |
| $4.73M | 1.09% | 0.00% | +190.0% | Q4 2018 | |
| $4.55M | 1.05% | 0.00% | -58.6% | Q1 2021 | |
| $4.35M | 1.00% | 0.00% | +4.1% | Q2 2019 | |
| $4.34M | 1.00% | 0.12% | +69.7% | Q4 2023 | |
| $4.29M | 0.99% | 0.07% | New | Q2 2026 | |
| $4.24M | 0.98% | 0.08% | +864.9% | Q4 2019 | |
| $4.22M | 0.97% | 0.01% | +301.3% | Q1 2019 | |
| $4.22M | 0.97% | 0.13% | Not reported | Q1 2021 | |
| $4.22M | 0.97% | 0.02% | +1087.7% | Q4 2018 | |
| $4.2M | 0.97% | 0.05% | +74.8% | Q4 2018 | |
| $4.2M | 0.97% | 0.19% | New | Q2 2026 | |
| $4.19M | 0.97% | 0.01% | +172.2% | Q3 2019 | |
| $4.19M | 0.97% | 0.06% | New | Q2 2026 | |
| $4.19M | 0.96% | 0.11% | Not reported | Q4 2018 | |
| $4.12M | 0.95% | 0.09% | Not reported | Q2 2025 | |
| $4.05M | 0.93% | 0.09% | Not reported | Q4 2024 | |
| $4M | 0.92% | 0.02% | Not reported | Q2 2025 | |
| $3.98M | 0.92% | 0.13% | Not reported | Q4 2023 | |
| $3.94M | 0.91% | 0.06% | +285.4% | Q1 2019 | |
| $3.68M | 0.85% | 0.03% | +268.8% | Q3 2023 | |
| $3.63M | 0.84% | 0.07% | +72.1% | Q1 2019 | |
| $3.48M | 0.80% | Not reported | Not reported | Q4 2018 | |
| $3.48M | 0.80% | 0.00% | Not reported | Q1 2019 | |
| $3.43M | 0.79% | 0.03% | Not reported | Q2 2019 | |
| $3.34M | 0.77% | 0.00% | Not reported | Q3 2019 | |
| $3.32M | 0.77% | 0.14% | Not reported | Q4 2025 | |
| $3.31M | 0.76% | 0.00% | +1.3% | Q4 2018 | |
| $3.3M | 0.76% | 0.07% | -41.7% | Q1 2026 | |
| $3.28M | 0.76% | 0.07% | +375.7% | Q1 2026 | |
| $3.13M | 0.72% | 0.00% | +112.0% | Q1 2019 | |
| $3.13M | 0.72% | 0.06% | +9.9% | Q2 2020 | |
| $3.07M | 0.71% | 0.00% | -2.2% | Q1 2020 | |
| $3.07M | 0.71% | 0.05% | -24.5% | Q3 2025 | |
| $3.03M | 0.70% | 0.01% | New | Q2 2026 | |
| $3M | 0.69% | 0.03% | +25.2% | Q4 2018 | |
| $3M | 0.69% | 0.00% | -3.5% | Q3 2020 | |
| $2.9M | 0.67% | 0.11% | Not reported | Q3 2025 | |
| $2.81M | 0.65% | 0.00% | -72.3% | Q2 2020 | |
| $2.76M | 0.64% | 0.02% | Not reported | Q1 2025 | |
| $2.73M | 0.63% | 0.00% | +100.5% | Q3 2020 | |
| $2.72M | 0.63% | 0.08% | +114.2% | Q1 2021 | |
| $2.65M | 0.61% | 0.00% | +10.0% | Q2 2019 | |
| $2.65M | 0.61% | 0.04% | +972.0% | Q4 2025 | |
| $2.64M | 0.61% | 0.08% | Not reported | Q1 2020 | |
| $2.6M | 0.60% | 0.00% | +30.1% | Q2 2019 | |
| Q1 2026Reported May 15, 2026315 positions | |||||
| $4.65M | 1.23% | 0.03% | +5.7% | Q4 2025 | |
| $4.56M | 1.20% | 0.00% | -33.7% | Q4 2018 | |
| $4.17M | 1.10% | 0.08% | Not reported | Q1 2019 | |
| $4.16M | 1.10% | Not reported | Not reported | Q3 2023 | |
| $4.07M | 1.07% | 0.01% | Not reported | Q1 2020 | |
| $3.92M | 1.03% | 0.09% | Not reported | Q1 2021 | |
| $3.92M | 1.03% | 0.19% | -40.2% | Q4 2025 | |
| $3.79M | 1.00% | 0.02% | New | Q1 2026 | |
| $3.77M | 0.99% | 0.02% | Not reported | Q2 2019 | |
| $3.74M | 0.99% | 0.02% | Not reported | Q3 2019 | |
| $3.66M | 0.97% | 0.00% | -35.6% | Q2 2019 | |
| $3.64M | 0.96% | 0.00% | +41.1% | Q4 2018 | |
| $3.61M | 0.95% | 0.01% | -46.0% | Q4 2018 | |
| $3.56M | 0.94% | 0.00% | Not reported | Q1 2019 | |
| $3.56M | 0.94% | 0.01% | -21.3% | Q4 2018 | |
| $3.4M | 0.90% | 0.00% | -42.1% | Q3 2023 | |
| $3.37M | 0.89% | 0.05% | Not reported | Q4 2018 | |
| $3.29M | 0.87% | 0.07% | Not reported | Q3 2020 | |
| $3.24M | 0.85% | 0.00% | Not reported | Q4 2018 | |
| $3.24M | 0.85% | Not reported | +26.6% | Q1 2025 | |
| $3.22M | 0.85% | 0.00% | Not reported | Q1 2021 | |
| $3.21M | 0.85% | 0.00% | -50.4% | Q2 2020 | |
| $3.1M | 0.82% | Not reported | -37.4% | Q4 2024 | |
| $3.08M | 0.81% | 0.06% | Not reported | Q1 2025 | |
| $3.06M | 0.81% | 0.10% | -28.9% | Q4 2024 | |
| $3.05M | 0.81% | 0.00% | +7.6% | Q4 2018 | |
| $3.03M | 0.80% | 0.00% | +0.7% | Q4 2019 | |
| $3.02M | 0.80% | 0.07% | +174.2% | Q4 2023 | |
| $3.01M | 0.79% | 0.04% | Not reported | Q1 2019 | |
| $2.94M | 0.78% | 0.00% | +80.2% | Q1 2020 | |
| $2.91M | 0.77% | 0.00% | +31.8% | Q4 2018 | |
| $2.86M | 0.75% | 0.00% | Not reported | Q3 2020 | |
| $2.83M | 0.75% | 0.00% | -51.3% | Q4 2019 | |
| $2.79M | 0.74% | 0.01% | Not reported | Q3 2019 | |
| $2.78M | 0.73% | 0.07% | Not reported | Q3 2025 | |
| $2.77M | 0.73% | 0.67% | -0.2% | Q2 2025 | |
| $2.7M | 0.71% | Not reported | +81.2% | Q4 2023 | |
| $2.7M | 0.71% | 0.00% | -62.1% | Q2 2019 | |
| ATFOLDAmicus Therapeutics, Inc. | $2.69M | 0.71% | 0.06% | -55.7% | Q1 2019 |
| $2.68M | 0.71% | 0.06% | Not reported | Q2 2020 | |
| $2.67M | 0.70% | 0.06% | Not reported | Q4 2024 | |
| $2.65M | 0.70% | 0.00% | -46.0% | Q4 2018 | |
| $2.64M | 0.70% | 0.11% | -26.6% | Q4 2024 | |
| $2.58M | 0.68% | Not reported | Not reported | Q4 2018 | |
| $2.52M | 0.66% | 0.00% | +48.6% | Q1 2019 | |
| $2.51M | 0.66% | 0.01% | Not reported | Q3 2020 | |
| $2.5M | 0.66% | 0.03% | -58.2% | Q4 2025 | |
| $2.49M | 0.66% | 0.02% | Not reported | Q1 2020 | |
| $2.49M | 0.66% | 0.06% | Not reported | Q2 2019 | |
| $2.49M | 0.66% | 0.02% | +1487.6% | Q4 2018 | |
| Q4 2025Reported Feb 13, 2026336 positions | |||||
| $7.61M | 1.20% | 0.02% | +38.8% | Q4 2018 | |
| $7.58M | 1.20% | Not reported | Not reported | Q1 2020 | |
| $7.56M | 1.19% | 0.01% | Not reported | Q2 2020 | |
| $7.41M | 1.17% | 0.05% | +43.8% | Q2 2025 | |
| $7.35M | 1.16% | 0.00% | +46.6% | Q4 2018 | |
| $7.13M | 1.13% | 0.00% | +63.4% | Q3 2023 | |
| $6.96M | 1.10% | 0.10% | Not reported | Q2 2025 | |
| $6.93M | 1.09% | 0.00% | Not reported | Q2 2019 | |
| $6.53M | 1.03% | 0.16% | +592.4% | Q2 2025 | |
| $6.44M | 1.02% | 0.07% | New | Q4 2025 | |
| $6.44M | 1.02% | 0.05% | Not reported | Q2 2020 | |
| $6.43M | 1.02% | 0.00% | +132.4% | Q1 2020 | |
| $6.37M | 1.01% | 0.32% | New | Q4 2025 | |
| $6.26M | 0.99% | 0.03% | +218.2% | Q4 2024 | |
| $6.22M | 0.98% | Not reported | +320.9% | Q3 2023 | |
| $6.2M | 0.98% | Not reported | Not reported | Q4 2023 | |
| $6.2M | 0.98% | Not reported | +197.3% | Q4 2024 | |
| $6.2M | 0.98% | Not reported | +159.2% | Q4 2024 | |
| $6.18M | 0.98% | 0.08% | +171.0% | Q4 2019 | |
| $6.16M | 0.97% | 0.08% | +301.9% | Q2 2019 | |
| $6.13M | 0.97% | 0.14% | +121.4% | Q4 2024 | |
| $6.13M | 0.97% | 0.00% | +359.9% | Q4 2019 | |
| $6.13M | 0.97% | 0.04% | Not reported | Q4 2019 | |
| $6.1M | 0.96% | 0.25% | +6773.7% | Q4 2024 | |
| $6.09M | 0.96% | 0.00% | +56.7% | Q2 2019 | |
| $6.07M | 0.96% | 0.05% | +187.2% | Q3 2023 | |
| ATFOLDAmicus Therapeutics, Inc. | $5.98M | 0.95% | 0.14% | +753.1% | Q1 2019 |
| $5.95M | 0.94% | 0.11% | +128.9% | Q4 2024 | |
| $5.9M | 0.93% | 0.00% | +83.9% | Q1 2019 | |
| $5.88M | 0.93% | 0.06% | +2825.9% | Q1 2020 | |
| $5.83M | 0.92% | 0.12% | New | Q4 2025 | |
| $5.41M | 0.85% | 0.00% | +227.8% | Q2 2020 | |
| $5.34M | 0.84% | 0.01% | Not reported | Q4 2018 | |
| $5.27M | 0.83% | 0.17% | New | Q4 2025 | |
| $5.19M | 0.82% | 0.07% | +61.5% | Q4 2018 | |
| $5.17M | 0.82% | 0.00% | +18.7% | Q4 2018 | |
| $5.17M | 0.82% | 0.00% | +1753.1% | Q2 2019 | |
| $5.06M | 0.80% | 0.05% | +68.7% | Q1 2019 | |
| $5.04M | 0.80% | 0.01% | +1234.6% | Q4 2024 | |
| $4.97M | 0.78% | 0.18% | New | Q4 2025 | |
| $4.69M | 0.74% | 0.16% | +54.1% | Q4 2019 | |
| $4.67M | 0.74% | 0.01% | Not reported | Q2 2020 | |
| $4.66M | 0.74% | 0.01% | Not reported | Q4 2018 | |
| $4.64M | 0.73% | 0.14% | Not reported | Q4 2024 | |
| $4.52M | 0.71% | 0.00% | +164.9% | Q1 2019 | |
| $4.42M | 0.70% | 0.04% | +212.8% | Q3 2025 | |
| $4.37M | 0.69% | 0.03% | New | Q4 2025 | |
| $4.21M | 0.67% | 0.08% | New | Q4 2025 | |
| $4.14M | 0.65% | 0.17% | New | Q4 2025 | |
| $4.13M | 0.65% | 0.08% | New | Q4 2025 | |
| Q3 2025Reported Nov 12, 2025373 positions | |||||
| $5.02M | 1.22% | 0.00% | +11.6% | Q4 2018 | |
| $5M | 1.22% | 0.01% | +18.7% | Q4 2018 | |
| $4.99M | 1.22% | 0.03% | +718.4% | Q4 2018 | |
| DDAYDayforce, Inc. | $4.8M | 1.17% | 0.04% | New | Q3 2025 |
| $4.58M | 1.12% | 0.00% | +93.1% | Q4 2018 | |
| $4.48M | 1.09% | 0.00% | +0.2% | Q3 2023 | |
| $4.2M | 1.02% | 0.00% | Not reported | Q4 2018 | |
| HHBIHanesbrands Inc. | $4.13M | 1.01% | 0.18% | Not reported | Q4 2018 |
| $3.96M | 0.97% | 0.20% | New | Q3 2025 | |
| CCFLTConfluent, Inc. | $3.86M | 0.94% | 0.18% | +239.8% | Q4 2024 |
| CFCADECadence Financial Corp | $3.85M | 0.94% | Not reported | +11.1% | Q4 2024 |
| $3.8M | 0.93% | 0.02% | New | Q3 2025 | |
| $3.75M | 0.91% | 0.00% | Not reported | Q4 2018 | |
| $3.65M | 0.89% | 0.00% | +70.8% | Q1 2019 | |
| $3.64M | 0.89% | Not reported | +12.8% | Q4 2024 | |
| $3.64M | 0.89% | 0.00% | +75.4% | Q2 2019 | |
| $3.62M | 0.88% | 0.08% | Not reported | Q1 2021 | |
| $3.59M | 0.88% | 0.03% | +229.6% | Q2 2025 | |
| $3.58M | 0.87% | 0.05% | Not reported | Q2 2019 | |
| $3.57M | 0.87% | Not reported | +52.7% | Q4 2024 | |
| $3.55M | 0.87% | 0.04% | Not reported | Q4 2018 | |
| $3.55M | 0.87% | 0.01% | Not reported | Q4 2018 | |
| $3.43M | 0.84% | 0.10% | New | Q3 2025 | |
| $3.38M | 0.82% | 0.00% | +385.0% | Q4 2018 | |
| $3.32M | 0.81% | 0.00% | +617.7% | Q3 2020 | |
| $3.31M | 0.81% | 0.04% | +35.8% | Q3 2023 | |
| $3.22M | 0.78% | 0.07% | Not reported | Q4 2024 | |
| $3.21M | 0.78% | 0.05% | Not reported | Q1 2019 | |
| $3.15M | 0.77% | Not reported | +87.6% | Q4 2024 | |
| $3.13M | 0.76% | 0.07% | Not reported | Q4 2023 | |
| $2.99M | 0.73% | 0.06% | +242.9% | Q2 2025 | |
| $2.99M | 0.73% | 0.01% | +17.2% | Q4 2024 | |
| $2.99M | 0.73% | 0.02% | Not reported | Q4 2018 | |
| $2.97M | 0.72% | 0.05% | -41.9% | Q4 2024 | |
| $2.96M | 0.72% | 0.03% | +69.1% | Q3 2020 | |
| $2.84M | 0.69% | 0.00% | Not reported | Q1 2019 | |
| $2.84M | 0.69% | 0.08% | Not reported | Q4 2024 | |
| $2.82M | 0.69% | 0.05% | +704.2% | Q1 2019 | |
| $2.8M | 0.68% | 0.07% | +73.4% | Q1 2021 | |
| $2.79M | 0.68% | 0.00% | +37.3% | Q4 2018 | |
| $2.72M | 0.66% | 0.53% | +273.5% | Q2 2025 | |
| $2.72M | 0.66% | 0.01% | -60.1% | Q3 2023 | |
| $2.62M | 0.64% | 0.03% | Not reported | Q2 2019 | |
| $2.61M | 0.64% | 0.10% | +121.1% | Q4 2019 | |
| $2.61M | 0.64% | 0.04% | +79.4% | Q3 2020 | |
| $2.59M | 0.63% | 0.33% | +331.4% | Q4 2019 | |
| $2.56M | 0.63% | 0.05% | -29.2% | Q4 2018 | |
| $2.52M | 0.61% | 0.01% | Not reported | Q3 2023 | |
| $2.49M | 0.61% | 0.02% | +14.0% | Q3 2023 | |
| $2.42M | 0.59% | 0.04% | +143.1% | Q4 2018 | |
Premium opens every quarter this fund has filed